PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 6EY6

#CDRs = 4; #Clusters = 4.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
I	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	12	AASGRTFSSYVMG	BBBEAAAAABBBB
I	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	9	AISWSGGSIH	BBBAALABBB
I	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
I	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	4	RDNAKNTV	BBAAALBB
J	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	13	AASGRTFSSYVMG	BBBEAAAAABBBB
J	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	8	AISWSGGSIH	BBBAALABBB
J	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
J	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	4	RDNAKNTV	BBAAALBB
K	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	12	AASGRTFSSYVMG	BBBEAAAAABBBB
K	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	8	AISWSGGSIH	BBBAALABBB
K	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
K	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	4	RDNAKNTV	BBAAALBB
L	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	12	AASGRTFSSYVMG	BBBEAAAAABBBB
L	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	9	AISWSGGSIH	BBBAALABBB
L	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
L	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	5	RDNAKNTV	BBAAALBB
M	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	12	AASGRTFSSYVMG	BBBEAAAAABBBB
M	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	8	AISWSGGSIH	BBBAALABBB
M	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
M	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	4	RDNAKNTV	BBAAALBB
N	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	13	AASGRTFSSYVMG	BBBEAAAAABBBB
N	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	8	AISWSGGSIH	BBBAALABBB
N	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
N	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	4	RDNAKNTV	BBAAALBB
O	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	13	AASGRTFSSYVMG	BBBEAAAAABBBB
O	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	9	AISWSGGSIH	BBBAALABBB
O	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
O	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	3	RDNAKNTV	BBAAALBB
P	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	92.3	H1	13	H1-13-3	12	AASGRTFSSYVMG	BBBEAAAAABBBB
P	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	80.0	H2	10	H2-10-2	9	AISWSGGSIH	BBBAALABBB
P	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	50.0	H3	23	H3-23-*	-1	VAgfagygsftSRSARDSDKYDY
P	heavy	Lama.glama	Al_IGHV3-3*01_VHH	97.3	Al_IGHV3-3*01_VHH	100.0	H4	8	H4-8-1	5	RDNAKNTV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022